• Team
  • Philosophy
  • Journal
  • LinkedIn

Mark C. Davies

Associate

Mark’s practice focuses on complex high stakes litigation. He has represented clients across a range of sectors, such as biotechnology, manufacturing  and  shipping

Mark has particular experience in class actions and matters involving the Anti-Kickback Statute and False Claims Act.  He also has an active pro bono practice which includes a successful amicus brief in a death row case before the Texas Court of Criminal Appeals.

Bull Hill v. HFZ and Monroe

Representing investors in inspection lawsuit to obtain corporate books and records relating to suspected misconduct and mismanagement of assets.

 

Offshore Appraisal Section 1782 Proceedings

Section 1782 discovery proceedings for dissenting shareholders pursuing billions of dollars in offshore shareholder appraisal claims, including in connection with the take-private mergers of SINA, Myovant Sciences, and New Frontier Health.

 

Kaisa Group Holdings

Representing Oasis Management as holder of NY-law governed bonds issued by Kaisa, a Chinese property conglomerate in default on billions of dollars of international obligations.

 

Norske Skog

Defending fraudulent transfer claims in Chapter 15 adversary proceedings brought by the trustee of Norske Skogindustrier, an insolvent Norwegian paper company, relating to a 2016 restructuring.

 

The Trevor Project

Representing The Trevor Project in connection with friend of the court submissions relating to LGBTQ+ rights.

New York University School of Law, J.D.; Commentary Editor, New York University Journal of International Law and Politics

Emory University, B.A., Political Science

New York

Southern District of New York

Eastern District of New York

U.S. Court of Appeals: Second Circuit

U.S. Court of Appeals: Fourth Circuit

U.S. Court of Appeals: Tenth Circuit

New York Metro, Super Lawyers Rising Star (2023-2024)

+1 (212) 970 2325

mark.davies@pallasllp.com

Related Articles

  • 6 June 2025

    News & Announcements

    Pallas Partners Files Amicus Brief on Behalf of The Trevor Project Supporting Michigan’s Ban on Conversion Therapy

    “Conversion ‘therapy’ is a harmful practice, not a form of treatment. Research has shown that it is linked to worse mental health outcomes and a significantly higher risk of suicide and other serious harms. We are grateful to partner with The Trevor Project in raising awareness about the importance of ensuring that children are protected against such dangerous and discredited practices.”

    6 June 2025

    News & Announcements

    Read Article
  • 13 September 2024

    News & Announcements

    Pallas Partners Supports The Trevor Project

    Our New York Partner Shireen Barday and Associate Mark Davies filed an amicus brief on behalf of the The Trevor Project in connection with a challenge to a transgender sports ban in Arizona. The brief had a positive impact: the Fifth Circuit Court of Appeals affirmed an order from the Arizona District Court preliminarily enjoining the State of Arizona from barring two transgender girls from playing on school sports teams consistent with their gender identity.

    13 September 2024

    News & Announcements

    Read Article
  • 18 April 2024

    Pallas Partners’ Amicus Brief on Behalf of The Trevor Project Results in Fourth Circuit Victory

    Our New York partner Shireen Barday and associate Mark Davies filed an amicus brief on behalf of The Trevor Project in connection with a challenge to a transgender sports ban in West Virginia, prohibiting transgender girls from playing on sports teams consistent with their gender identities.

    18 April 2024

    Read Article
  • 17 April 2024

    News & Announcements

    Pallas Partners Succeed in Section 1782 Proceedings

    As part of our cross-border shareholder appraisal practice, our New York partner Duane Loft and associates Briannna Simopoulos and Mark Davies secured an important decision granting Section 1782 discovery in support of Bermuda appraisal litigation relating to the US$1.7 billion acquisition of Myovant Sciences.

    17 April 2024

    News & Announcements

    Read Article
Back to Team
    • LinkedIn
    • Instagram
    • Privacy Statement
    • Legal Notices
    • Cookies Policy

    Attorney Advertising.
    Prior results do not guarantee a similar outcome.

    Pallas Partners 2025